Presentation is loading. Please wait.

Presentation is loading. Please wait.

Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid  Anne-Kathrin Kienzler, MSc, Marta Rizzi, MD,

Published byStina Egeland Modified over 5 years ago

Similar presentations

Presentation on theme: "Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid  Anne-Kathrin Kienzler, MSc, Marta Rizzi, MD,"— Presentation transcript:

1 Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid  Anne-Kathrin Kienzler, MSc, Marta Rizzi, MD, PhD, Maike Reith, MSc, Stephen L. Nutt, PhD, Hermann Eibel, PhD  Journal of Allergy and Clinical Immunology  Volume 131, Issue 6, Pages e9 (June 2013) DOI: /j.jaci Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 B-cell phenotype and immunoglobulin secretion. Cells were stimulated as indicated. A, Naive B cells. Percentage of CD27highCD38high cells within live CD19+ cells is indicated. Absolute counts of CD27highCD38high cells of activated naive (B) and memory (C) B cells 9 days after activation. IgM (D), IgG (E and G), and IgA (F and H) concentrations in culture supernatant fluids of naive (D-F) and memory (G and H) B cells 9 days after stimulation. Each symbol represents one independent experiment; ns, Not significant. **P < .01. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 B-cell viability and proliferation. Naive B cells were stimulated as indicated for 6 days. A, Percentages of live (AnnexinV−PI−), dead (AnnexinV+PI+) and apoptotic (AnnexinV+PI−) cells determined. B and C, B cell proliferation was analyzed by CFSE labeling. CD27 (D) and CD38 (E) expression within CFSE-labeled CD19+ cells. A, Each symbol represents one independent experiment; B, D, and E are representative for 6 independent experiments; C is representative for 3 independent experiments; BAFF, B-cell activating factor; ns, not significant. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig E1 Memory B-cell differentiation into plasmablasts is not influenced by VPA treatment, whereas naive B-cell differentiation is affected in a dose-dependent manner. A, Representative flow cytometric analysis of human memory B cells stimulated with CD40L and IL-21 in the presence or absence of VPA as indicated. Percentage of CD27highCD38high cells within live CD19+ cells is shown. B, Percentage of CD27high CD38high cells from 3 different donors activated and analyzed as shown in A. C, Naive B cells were stimulated as indicated. Absolute count of CD27highCD38high cells 6 days after activation is plotted on the y axis. Each symbol represents one independent experiment; ns, Not significant; *P < .05. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig E2 VPA inhibits blast formation and early expression of CD69, induces MHC class II expression, but does not influence CD86 expression and calcium influx on BCR stimulation. Naive B cells were stimulated as indicated. A and B, Blast formation was determined by analyzing cell size by forward scatter in flow cytometry. Expression of the early activation markers CD69 (C and D), HLA-DR (E and F), and CD86 (G and H) analyzed by flow cytometry. A, C, E, and G are representative FACS plots; (B, D, F, and H) depict the median fluorescence intensity over time. Each symbol represents one independent experiment. I, Calcium influx on BCR stimulation of VPA-treated compared with untreated cells. Shown is 1 representative of 2 independent experiments. BCR, B-cell receptor; FSC, forward scatter; HLA-DR, human leukocyte antigen DR; FACS, fluorescence-activated cell sorting; MFI, median fluorescence intensity; ns, not significant. *P < .05. **P < .01. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig E3 No variation in expression of B-cell fate–determining genes in the presence of VPA. Naive B cells were activated as indicated. mRNA levels of AICDA (A), PRDM1 (B), XBP1 (C), IRF4 (D), BCL6 (E), and PAX5 (F) were determined by quantitative PCR at indicated time points. Each symbol represents one independent experiment. AICDA, Activation-induced cytidine deaminase; PRDM1, PR domain containing 1, with ZNF domain; XBP1, X-box binding protein 1; IRF4, interferon regulatory factor 4; BCL6, B-cell CLL/lymphoma 6; PAX5, paired box 5. *P < .05. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig E4 VPA at a dose of 0.25 mmol/L does not induce apoptosis, but inhibits B- and T-cell proliferation. (A-E, H, and I) Naive B cells or PBMCs (F and G) were stimulated as indicated for 6 days. A, Percentages of live (AnnexinV−PI−) and dead (AnnexinV+PI+) cells, including apoptotic (AnnexinV+PI−) cells. B-G, Lymphocyte proliferation was analyzed by CFSE labeling. B, B-cell proliferation in the presence of escalating doses of VPA. C and F, Representative FACS plot showing the gating strategy for statistical analysis of proliferation. D, E, and G, Percentage of cells that have undergone indicated numbers of divisions. Statistics was performed for cells that have undergone 3 or more divisions. Percentage of CFSElow and CD27high (H) or CD38high (I) cells gated on CD19+ cells for 8 independent experiments. In A, D, E, and G-I each symbol represents 1 independent experiment; in B each symbol represents the mean of 2 independent experiments. PI, Propidium iodide; α-, anti-; BAFF, B-cell activating factor; lo, low expression; hi, high expression; ns, not significant. *P < .05. **P < .01. ***P < .001. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 Fig E5 CD40 and IL-21R expression and JAK-STAT signaling in B cells are not modulated by VPA. (A-K, Naive B cells were stimulated as indicated.) A and B, Cell surface expression of CD40. A, Representative FACS plot. B, MFI of CD40 in 3 independent experiments. C-E, IL-21R expression. C, Variation of relative IL-21R mRNA expression over time in culture. D, Representative FACS plot. E, MFI of IL-21R in 4 independent experiments. Relative mRNA levels of JAK3 (F), STAT3 (G), STAT5A (H), and STAT5B (I) over time in culture. Each symbol represents one independent experiment. J, Cells were lysed after 6 days in culture either directly, or after 15 minutes (K) of pulse stimulation with IL-21. Lysates were analyzed by Western blot analysis with the use of antibodies specific for JAK3 and STAT5 or their phosphorylated forms, and for β-actin. L, MEC1 cells were cultured as indicated. Cells were lysed after 4 days either directly (lane 1) or after 15 minutes of pulse stimulation with IL-21 (lanes 2-3). Lysates were analyzed by Western blot analysis with the use of an antibody specific for STAT3 or its phosphorylated form. (p)JAK3, (phospho) Janus kinase 3; (p)STAT3, 5A, 5B, (phospho) signal transducer and activator of transcription 3, 5 isoform A and B; t=0, before activation; d3, 3 days after activation; FACS, fluorescence-activated cell sorting; MFI, median fluorescence intensity; ns, not significant. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid  Anne-Kathrin Kienzler, MSc, Marta Rizzi, MD,"

Similar presentations

Barbara Stanic, PhD, Willem van de Veen, PhD, Oliver F

Barbara Stanic, PhD, Willem van de Veen, PhD, Oliver F
Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma  Alessia Scarselli, MD, Silvia Di Cesare, BSc, Gigliola Di Matteo,

Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma  Alessia Scarselli, MD, Silvia Di Cesare, BSc, Gigliola Di Matteo,
Correlation of allergen-specific T follicular helper cell counts with specific IgE levels and efficacy of allergen immunotherapy  Yin Yao, MD, Cai-Ling.

Correlation of allergen-specific T follicular helper cell counts with specific IgE levels and efficacy of allergen immunotherapy  Yin Yao, MD, Cai-Ling.
William A. Comrie, PhD, Aiman J

William A. Comrie, PhD, Aiman J
IgE cross-linking impairs monocyte antiviral responses and inhibits influenza-driven TH1 differentiation  Regina K. Rowe, MD, PhD, David M. Pyle, MD,

IgE cross-linking impairs monocyte antiviral responses and inhibits influenza-driven TH1 differentiation  Regina K. Rowe, MD, PhD, David M. Pyle, MD,
Reduced IFN-γ receptor expression and attenuated IFN-γ response by dendritic cells in patients with atopic dermatitis  Eva Gros, MSc, Susanne Petzold,

Reduced IFN-γ receptor expression and attenuated IFN-γ response by dendritic cells in patients with atopic dermatitis  Eva Gros, MSc, Susanne Petzold,
Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of TH1/TFH signatures  Jelle de Wit, PhD, Tineke Jorritsma,

Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of TH1/TFH signatures  Jelle de Wit, PhD, Tineke Jorritsma,
Toll-like receptor 7–induced naive human B-cell differentiation and immunoglobulin production  Mark C. Glaum, MD, PhD, Shilpi Narula, MD, Decheng Song,

Toll-like receptor 7–induced naive human B-cell differentiation and immunoglobulin production  Mark C. Glaum, MD, PhD, Shilpi Narula, MD, Decheng Song,
Interferon response factor 3 is essential for house dust mite–induced airway allergy  Thomas Marichal, DVM, Denis Bedoret, DVM, PhD, Claire Mesnil, DVM,

Interferon response factor 3 is essential for house dust mite–induced airway allergy  Thomas Marichal, DVM, Denis Bedoret, DVM, PhD, Claire Mesnil, DVM,
Ting-ting Zhang, MSc, Klaus Okkenhaug, PhD, Baher F

Ting-ting Zhang, MSc, Klaus Okkenhaug, PhD, Baher F
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)  Aleena.

Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)  Aleena.
B-cell receptor cross-linking delays activation-induced cytidine deaminase induction and inhibits class-switch recombination to IgE  Haifa H. Jabara,

B-cell receptor cross-linking delays activation-induced cytidine deaminase induction and inhibits class-switch recombination to IgE  Haifa H. Jabara,
Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival  Jyoti Balhara, MSc, Lianyu Shan,

Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival  Jyoti Balhara, MSc, Lianyu Shan,
Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions  Mauro Giacomelli, PhD, Rajesh.

Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions  Mauro Giacomelli, PhD, Rajesh.
IL-4 confers resistance to IL-27–mediated suppression on CD4+ T cells by impairing signal transducer and activator of transcription 1 signaling  Zhihong.

IL-4 confers resistance to IL-27–mediated suppression on CD4+ T cells by impairing signal transducer and activator of transcription 1 signaling  Zhihong.
IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycin  Robert J. Salmond, PhD, Ananda S. Mirchandani,

IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycin  Robert J. Salmond, PhD, Ananda S. Mirchandani,
Type 3 innate lymphoid cells induce proliferation of CD94+ natural killer cells  Shuo Li, PhD, Hideaki Morita, MD, PhD, Beate Rückert, Sci Tec, Tadech.

Type 3 innate lymphoid cells induce proliferation of CD94+ natural killer cells  Shuo Li, PhD, Hideaki Morita, MD, PhD, Beate Rückert, Sci Tec, Tadech.
Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin  Mohan S. Maddur, DVM, Janakiraman Vani,

Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin  Mohan S. Maddur, DVM, Janakiraman Vani,
Carole Le Coz, PhD, Melissa Trofa, BA, Camille M

Carole Le Coz, PhD, Melissa Trofa, BA, Camille M
IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis  Stéphanie.

IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis  Stéphanie.

Similar presentations

Ads by Google